Sonder Capital has officially closed its second fund, Futures II, bringing together capital commitments from prominent healthcare systems including Mayo Clinic and Sutter Health. The partnership demonstrates growing institutional interest in early-stage healthcare innovation and provides a strong financial base for the fund’s initial investments.

Futures II will concentrate on AI-enabled medical robotics and minimally invasive therapies, aiming to create new care pathways and business models. Sonder’s previous successes, such as launching Procept Biorobotics, highlight the firm’s ability to nurture companies that transform surgical standards and patient outcomes.